| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Aug―03 |
Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact |
Javier Olazarán, Cristóbal Carnero-Pardo, Juan Fortea, Pascual Sánchez-Juan, Guillermo García-Ribas, Félix Viñuela, Pablo Martínez-Lage, Mercè Boada |
| 2 |
[GO] |
2023―Apr―15 |
Steeper memory decline after COVID-19 lockdown measures |
Els D. Bakker, Stéphanie L. van der Pas, Marissa D. Zwan, Freek Gillissen, Femke H. Bouwman, Philip Scheltens, Wiesje M. van der Flier, Ingrid S. van Maurik |
| 3 |
[GO] |
2023―Jan―06 |
Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project |
Juraj Secnik, Maria Eriksdotter, Hong Xu, Martin Annetorp, Aleksander Rytarowski, Kristina Johnell, Sara Hägg, Dorota Religa |
| 4 |
[GO] |
2022―Sep―06 |
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid? |
Muge Akinci, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, Cleofé Peña-Gómez, Eleni Palpatzis, Mahnaz Shekari, Carme Deulofeu, Sherezade Fuentes-Julian, Gemma Salvadó, José Maria González-de-Echávarri, Marc Suárez-Calvet, Carolina Minguillón, Karine Fauria, José Luis Molinuevo, Juan Domingo Gispert, Oriol Grau-Rivera, Eider M. Arenaza-Urquijo, Annabella Beteta, Raffaele Cacciaglia, Alba Cañas, Irene Cumplido, Ruth Dominguez, Maria Emilio, Carles Falcon, Laura Hernandez, Gema Huesa, Jordi Huguet, Paula Marne, Tania Menchón, Grégory Operto, Albina Polo, Blanca Rodríguez-Fernández, Sandra Pradas, Iman Sadeghi, Anna Soteras, Laura Stankeviciute, Marc Vilanova, Natalia Vilor-Tejedor |
| 5 |
[GO] |
2021―Dec―20 |
Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study |
Lon S. Schneider, Yuqi Qiu, Ronald G. Thomas, Carol Evans, Diane M. Jacobs, Shelia Jin, Jeffrey A. Kaye, Andrea Z. LaCroix, Karen Messer, David P. Salmon, Mary Sano, Kimberly Schafer, Howard H. Feldman |
| 6 |
[GO] |
2021―Jun―12 |
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again? |
Nian Xiong, Martin R. Schiller, Jingwen Li, Xiaowu Chen, Zhicheng Lin |
| 7 |
[GO] |
2021―Jun―09 |
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment |
Yadi Zhou, Jielin Xu, Yuan Hou, James B. Leverenz, Asha Kallianpur, Reena Mehra, Yunlong Liu, Haiyuan Yu, Andrew A. Pieper, Lara Jehi, Feixiong Cheng |
| 8 |
[GO] |
2021―Apr―10 |
COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients |
Agathe Vrillon, Elsa Mhanna, Clément Aveneau, Manon Lebozec, Lina Grosset, Diane Nankam, Fernanda Albuquerque, Raphaelle Razou Feroldi, Barbara Maakaroun, Iana Pissareva, Dalenda Cherni Gherissi, Julien Azuar, Véronique François, Claire Hourrègue, Julien Dumurgier, Lisette Volpe-Gillot, Claire Paquet |
| 9 |
[GO] |
2020―Dec―30 |
Cognitive impact of COVID-19: looking beyond the short term |
Scott Miners, Patrick G. Kehoe, Seth Love |
| 10 |
[GO] |
2020―Jun―04 |
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease |
Michael T. Heneka, Douglas Golenbock, Eicke Latz, Dave Morgan, Robert Brown |
|
